Codes / ICD10CM / D72.118

D72.118 Other hypereosinophilic syndrome

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Other hypereosinophilic syndrome
  • Medical Terms: Other hypereosinophilic syndrome

Summary

Other hypereosinophilic syndrome is a condition marked by persistently elevated eosinophil levels in the blood and tissues, leading to organ damage. It is a diagnosis of exclusion, meaning other causes of eosinophilia must be ruled out. The condition can affect multiple organ systems, including the heart, lungs, skin, and nervous system.

Causes

The exact cause of other hypereosinophilic syndrome is often unknown, though it may involve abnormal growth of eosinophils due to genetic mutations or dysregulated immune responses. Some cases are associated with clonal hematopoiesis, where eosinophils proliferate uncontrollably. In rare instances, it may be linked to underlying hematologic disorders.

Risk Factors

  • Persistent eosinophilia without a known cause
  • Family history of hematologic disorders
  • Exposure to certain medications or environmental triggers (e.g., allergens)
  • Underlying autoimmune or inflammatory conditions

Symptoms

  • Fatigue and weakness
  • Cough, shortness of breath, or chest pain (if lungs are involved)
  • Skin rashes, itching, or nodules
  • Abdominal pain, diarrhea, or nausea (if gastrointestinal tract is affected)
  • Neurological symptoms (e.g., confusion, numbness) in severe cases
  • Heart-related symptoms (e.g., palpitations, heart failure)

Diagnosis

Diagnosis involves confirming persistently elevated eosinophil counts and ruling out other causes of eosinophilia through clinical evaluation, laboratory tests, and imaging. Bone marrow biopsy may be performed to assess for clonal hematopoiesis. Additional tests, such as genetic studies or organ-specific evaluations, may be used to identify underlying mechanisms.

Treatment Options

Treatment focuses on reducing eosinophil levels and managing organ damage. Corticosteroids are often first-line therapy. Other options include targeted therapies (e.g., monoclonal antibodies), chemotherapy, or hematopoietic stem cell transplantation in severe cases. Symptomatic treatment addresses organ-specific complications.

Prognosis and Follow-Up

Prognosis varies based on organ involvement and response to treatment. Regular monitoring of eosinophil counts and organ function is essential. Long-term follow-up may be required to manage chronic symptoms or complications.

Complications

  • Organ damage (e.g., heart failure, lung fibrosis)
  • Thromboembolic events
  • Neurological impairment
  • Skin or gastrointestinal complications

Lifestyle & Prevention

  • Avoid known triggers (e.g., allergens, certain medications)
  • Maintain regular medical follow-up
  • Manage underlying conditions that may contribute to eosinophilia

When to Seek Professional Help

Seek care if experiencing persistent symptoms (e.g., unexplained fatigue, organ-specific issues) or if eosinophil levels are elevated without a clear cause.

Tips for Medical Coders

Document the specific subtype or underlying cause when available, as this may impact coding. Ensure clinical correlation with eosinophil levels and organ involvement to support the diagnosis.

Book a walkthrough

D72.118 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.